Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Médica de Risaralda
Print version ISSN 0122-0667
Abstract
SANCHEZ HERNANDEZ, Verónica; MORALES PEREZ, Marlen and OSORIO ESPINOZA, Angélica. Polypharmacy for patients with chronic-degenerative diseases in a remote community, Puebla- México. Revista médica Risaralda [online]. 2022, vol.28, n.2, pp.127-138. Epub Dec 27, 2022. ISSN 0122-0667. https://doi.org/10.22517/25395203.25046.
Objective:
To determine if patients with chronic degenerative diseases between 50-90 years of age have polypharmacy and drug interactions, at the Huajoyuca Health Center of Palacios, between June 2018-June 2019.
Methodology:
A descriptive, observational, non-experimental, statistical, retrospective, cross-sectional, unicentric research was carried out. The sample consisted of 56 files according to the inclusion criteria. Data were analyzed according to descriptive statistics and frequency histograms.
Results:
The mean age is 67.11 ± 9.6 years. There was a higher prevalence of polypharmacy in the 60-69 age range. Due to excessive medication consumption, women make up 82 percent of those affected. Patients with chronic-degenerative disorders are the most likely to have polypharmacy, and those with comorbid conditions even more, it was observed that the consumption and frequency of medications per patient is 4.08 ± 1.56 medications. The top drugs consumed daily are metformin (17.41%), hydrochlorothiazide (12.05%), B vitamin, acetylsalicylic acid glibenclamide with (11.16%), losartan (8.03%), enalapril (6.69%), captopril (4.91 %). 38 patients with (68%) had minor polypharmacy, 17 patients with (30%) had major polypharmacy, and 1 patient with (2%), had excess polypharmacy.
Conclusion:
In order from highest to lowest, patients with type 2 diabetes mellitus have minor polypharmacy, unlike hypertensive and dyslipidemic patients. The gender most affected by polypharmacy is the female with 82% vs. 18% the male gender of the population studied.
Keywords : Diabetes Mellitus type 2; Polypharmacy; Chronic Diseases; Dyslipidemia; Systemic Arterial Hypertension.
![](/img/en/iconPDFDocument.gif)